Science
Mechanism of Action
Lysophosphatidic Acid (LPA) modulates skin function by engaging LPAR1 and LPAR5 receptors on keratinocytes. This interaction activates the RHO-ROCK-SRF pathway, upregulating filaggrin (FLG) expression crucial for barrier integrity and facilitating keratinocyte differentiation. LPA also increases profilaggrin and serine palmitoyltransferase (SPT) mRNA expression via Ca2+ influx modulation, enhancing skin moisturization and barrier strength. Sodium cyclic lysophosphatidic acid (NcPA), a specific LPA variant, further boosts skin moisture by stimulating hyaluronic acid synthesis. Additionally, LPA influences keratinocyte proliferation, differentiation, and broader skin repair processes through various complex signaling pathways.
Research
Clinical Evidence
Medium confidence0.1%
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Lysophosphatidic Acid (LPA) is a dynamic molecule whose content can vary with storage conditions and in the presence of certain chemicals. For analytical purposes, concentrated stock solutions are stable at -80°C for 6 months or -20°C for 1 month, with fresh preparation recommended for working solutions. Heat and/or sonication can assist dissolution if precipitation occurs. Optimal pH range for cosmetic formulation stability is not specified in current research.
Conflicts
- EDTA (Ethylenediaminetetraacetic acid)
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) and Scientific Committee on Consumer Safety (SCCS) have not published specific safety assessments for Lysophosphatidic Acid as a cosmetic ingredient. The FDA advises manufacturers to ensure product safety, though it does not mandate premarket approval for most cosmetic ingredients.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Lysophosphatidic Acid is a valuable ingredient for improving skin barrier function, enhancing hydration, and offering anti-aging benefits, making it particularly beneficial for dry and sensitive skin types.
Related
Similar Ingredients
Finding similar ingredients…